The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N1-(2-(6H-indolo[2,3-b]quinoxalin-6-yl)ethyl)-N2,N2-dimethylethane-1,2-diamine ID: ALA4092501
PubChem CID: 137653465
Max Phase: Preclinical
Molecular Formula: C20H23N5
Molecular Weight: 333.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)CCNCCn1c2ccccc2c2nc3ccccc3nc21
Standard InChI: InChI=1S/C20H23N5/c1-24(2)13-11-21-12-14-25-18-10-6-3-7-15(18)19-20(25)23-17-9-5-4-8-16(17)22-19/h3-10,21H,11-14H2,1-2H3
Standard InChI Key: PEKKLDGFPWCPEY-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
0.8612 -17.8709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8600 -18.6904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5681 -19.0994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5663 -17.4620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2749 -17.8673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2757 -18.6863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9842 -19.0933 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9786 -17.4570 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6877 -17.8604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6954 -18.6795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4767 -18.9254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4644 -17.6001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9498 -18.2584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7607 -18.1664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0872 -17.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5967 -16.7582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7875 -16.8535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7372 -19.6999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5383 -19.8616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7988 -20.6361 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5998 -20.7978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8603 -21.5723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6614 -21.7340 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9219 -22.5085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2019 -21.1211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 2 0
9 8 2 0
8 5 1 0
9 10 1 0
10 11 1 0
11 13 1 0
12 9 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
11 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
23 25 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 333.44Molecular Weight (Monoisotopic): 333.1953AlogP: 2.89#Rotatable Bonds: 6Polar Surface Area: 45.98Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.85CX LogP: 3.05CX LogD: 0.64Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.55Np Likeness Score: -1.25
References 1. Klimenko K, Lyakhov S, Shibinskaya M, Karpenko A, Marcou G, Horvath D, Zenkova M, Goncharova E, Amirkhanov R, Krysko A, Andronati S, Levandovskiy I, Polishchuk P, Kuz'min V, Varnek A.. (2017) Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents., 27 (16): [PMID:28666733 ] [10.1016/j.bmcl.2017.06.035 ]